Last updated on February 2019

Evaluation of the Efficacy Safety and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms


Brief description of study

This study evaluates the safety, tolerability and efficacy of Sarizotan in reducing respiratory abnormalities in Rett Syndrome.

Detailed Study Description

This is a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and efficacy of multiple doses of sarizotan in patients with Rett syndrome with respiratory abnormalities. The study participants will be randomized to either sarizotan between 2 and 10 mg bid or placebo bid, based on age and weight criteria.

Clinical Study Identifier: NCT02790034

Contact Investigators or Research Sites near you

Start Over

Arthur Beisang, MD

Gillette Children's Specialty Healthcare
Saint Paul, MN United States
0.17miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.